Applicant, as named in the Orange Book

Teva Pharms Inc

Teva Pharmaceutical Industries Ltd · NYSE: TEVA

Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings

Next listed expiry: Alvaiz on 5 Nov 2038. 1 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Alvaiz NDA 216774 · 4 strengths eltrombopag choline	eltrombopag choline	5 Nov 2038 patent	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	Earliest generic entry	Basis
Paclitaxel NDA 216338 paclitaxel	paclitaxel	open now no listed protection	no listed protection